Accumulation, page-119

Hi Heraclitus

I agree that perspective should not be lost however I do note that the table you posted from the company's announcement includes ResApp, which currently has nil revenue but the MC and shareprice have obviously been based on revenue potential.

I would put it to you that based on future revenue potential that Alcidion also has a unique first mover product that is already being sold into hospitals. Hospitals would not be prepared to spend $Millions on a product unless it actually performed due to strict patient safety requirements.

I also suspect that $5 million revenue for 2015 is now well out of date and that with over $15 million spent in the past on product development that will no longer need to be forked out, I would think that Alcidion will be looking to moving into a profit making position in the not too distant future.

Finally, if you add the Obama Care legislation and the potential sales to 8000 US hospitals.....7 cents per share is probably not expensive at all.

Just my take on this little company.